🎉 M&A multiples are live!
Check it out!

Centessa Pharmaceuticals Valuation Multiples

Discover revenue and EBITDA valuation multiples for Centessa Pharmaceuticals and other public comps.

See Centessa Pharmaceuticals Valuation Multiples

Centessa Pharmaceuticals Overview

About Centessa Pharmaceuticals

Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include 1) SerpinPC for Hemophilia A, B, 2) LB101 for Solid Tumors, 3) ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders, 4) MGX292 Pulmonary Arterial Hypertension (PAH) and 5) Undisclosed for Solid Tumors.


Founded

2020

HQ

Germany
Employees

153

Website

centessa.com

Financials

LTM Revenue n/a

LTM EBITDA n/a

EV

$1.9B

Valuation Multiples

Multiples.vc

Sign up to see

Valuation Multiples for 10K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Centessa Pharmaceuticals Financials

Centessa Pharmaceuticals has a last 12-month revenue of n/a and a last 12-month EBITDA of n/a.

In the most recent fiscal year, Centessa Pharmaceuticals achieved revenue of $7.1M and an EBITDA of -$172M.

Centessa Pharmaceuticals expects next 12-month revenue of  XXX    and NTM EBITDA of  XXX

See Centessa Pharmaceuticals valuation multiples based on analyst estimates

Centessa Pharmaceuticals P&L

FY 2022 FY 2023 FY 2024 LTM NTM
Revenue n/a n/a $7.1M n/a XXX
Gross Profit n/a n/a n/a XXX XXX
Gross Margin NaN% NaN% NaN% XXX XXX
EBITDA n/a -$219M -$172M n/a XXX
EBITDA Margin NaN% -Infinity% -2414% NaN% XXX
Net Profit n/a -$225M -$157M XXX XXX
Net Margin NaN% -Infinity% -2205% XXX XXX
Net Debt n/a n/a n/a XXX XXX

Financial data powered by Morningstar, Inc.

Centessa Pharmaceuticals Stock Performance

As of February 7, 2025, Centessa Pharmaceuticals's stock price is EUR 17 (or $18).

Centessa Pharmaceuticals has current market cap of EUR 2.3B (or $2.4B), and EV of EUR 1.8B (or $1.9B).

See Centessa Pharmaceuticals trading valuation data

Centessa Pharmaceuticals Stock Data

EV Market Cap Price 1D Price 1M Price 3M Price 12M EPS
$1.9B $2.4B XXX XXX XXX XXX n/a

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Sign Up

Centessa Pharmaceuticals Valuation Multiples

As of February 7, 2025, Centessa Pharmaceuticals has market cap of $2.4B and EV of $1.9B.

Centessa Pharmaceuticals's trades at n/a LTM EV/Revenue multiple, and n/a LTM EBITDA.

Analysts estimate Centessa Pharmaceuticals's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See valuation multiples for Centessa Pharmaceuticals and 10K+ public comps

Centessa Pharmaceuticals Financial Valuation Multiples

FY 2024 FY 2025E FY 2026E FY 2027E
EV $1.9B XXX XXX XXX
EV/Revenue n/a XXX XXX XXX
EV/EBITDA n/a XXX XXX XXX
P/E n/a XXX XXX XXX
P/E/Growth n/a XXX XXX XXX
EV/FCF n/a XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Centessa Pharmaceuticals Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Sign Up

Centessa Pharmaceuticals Valuation Multiples

Centessa Pharmaceuticals's NTM/LTM revenue growth is n/a

Centessa Pharmaceuticals's revenue per employee for the last fiscal year averaged $47K, while opex per employee averaged $1.2M for the same period.

Over next 12 months, Centessa Pharmaceuticals's ratio of sales and marketing spend to revenue is estimated to be  XXX , while its R&D spend to revenue to be  XXX .

Analysts estimate Centessa Pharmaceuticals's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See operational valuation multiples for Centessa Pharmaceuticals and other 10K+ public comps

Centessa Pharmaceuticals Operational Valuation Multiples

FY 2024 NTM FY 2025E FY 2026E FY 2027E
Revenue Growth Infinity% XXX XXX XXX XXX
EBITDA Margin n/a XXX XXX XXX XXX
EBITDA Growth -21% XXX XXX XXX XXX
Rule of 40 (SaaS-only) n/a XXX XXX XXX XXX
Revenue per Employee $47K XXX XXX XXX XXX
Opex per Employee $1.2M XXX XXX XXX XXX
S&M Expenses to Revenue n/a XXX XXX XXX XXX
G&A Expenses to Revenue 784% XXX XXX XXX XXX
R&D Expenses to Revenue 1815% XXX XXX XXX XXX
Opex to Revenue 2599% XXX XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics
Pharma Analytics
Private Equity
ERP Software
Medical Devices
Consumer SaaS
Streaming Platforms
AdTech Software
Climate Tech
GRC Software
Developer Tools

Centessa Pharmaceuticals Public Comps

See valuation multiples for Centessa Pharmaceuticals public comps
EV/Revenue EV/EBITDA
2025E 2026E 2027E 2025E 2026E 2027E
Julphar XXX XXX XXX XXX XXX XXX
Benevolent AI XXX XXX XXX XXX XXX XXX
Galapagos XXX XXX XXX XXX XXX XXX
Pharming XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX

Valuation data powered by FactSet, Inc.

Centessa Pharmaceuticals M&A and Investment Activity

Centessa Pharmaceuticals acquired  XXX companies to date.

Last acquisition by Centessa Pharmaceuticals was  XXXXXXXX, XXXXX XXXXX XXXXXX . Centessa Pharmaceuticals acquired  XXXXXXXX for  XXX (EV/Revenue multiple of  XXX ).

See M&A valuation multiples

Latest Acquisitions by Centessa Pharmaceuticals

Acquired Company EV EV/Revenue EV/EBITDA
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.

Sign Up

About Centessa Pharmaceuticals

When was Centessa Pharmaceuticals founded? Centessa Pharmaceuticals was founded in 2020.
Where is Centessa Pharmaceuticals headquartered? Centessa Pharmaceuticals is headquartered in Germany.
How many employees does Centessa Pharmaceuticals have? As of today, Centessa Pharmaceuticals has 153 employees.
Who is the CEO of Centessa Pharmaceuticals? Centessa Pharmaceuticals's CEO is Dr. Saurabh Saha, M.D.,PhD.
Is Centessa Pharmaceuticals publicy listed? Yes, Centessa Pharmaceuticals is a public company listed on DUS.
What is the stock symbol of Centessa Pharmaceuticals? Centessa Pharmaceuticals trades under 260 ticker.
When did Centessa Pharmaceuticals go public? Centessa Pharmaceuticals went public in 2021.
Who are competitors of Centessa Pharmaceuticals? Similar companies to Centessa Pharmaceuticals include e.g. Julphar, Benevolent AI, Galapagos, Pharming.
What is the current market cap of Centessa Pharmaceuticals? Centessa Pharmaceuticals's current market cap is $2.4B
Is Centessa Pharmaceuticals profitable? Yes, Centessa Pharmaceuticals is EBITDA-positive (as of the last 12 months).

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.